Author Index

Search or browse for an author across our entire electronic archive

Search results for: G
Results 251 - 260 of 1441 shown below

  • Garrett, C

    M Javle, J Yu, C Garrett, A Pande, B Kuvshinoff, A Litwin, J Phelan, J Gibbs and R Iyer

    Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study

    advance online publication, 2009-06-02 00:00:00.000;

    doi:10.1038/sj.bjc.6605099

  • Garrett, M

    C Benson, S Kaye, P Workman, M Garrett, M Walton and J de Bono

    Clinical anticancer drug development: targeting the cyclin-dependent kinases

    advance online publication, 2004-11-23 00:00:00.000;

    doi:10.1038/sj.bjc.6602229

  • Garrett, M D

    J F Knight, C J Shepherd, S Rizzo, D Brewer, S Jhavar, A R Dodson, C S Cooper, R Eeles, A Falconer, G Kovacs, M D Garrett, A R Norman, J Shipley and D L Hudson

    TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer

    advance online publication, 2008-11-11 00:00:00.000;

    doi:10.1038/sj.bjc.6604774

  • Garrett-Mayer, E

    J Shrout, M Yousefzadeh, A Dodd, K Kirven, C Blum, A Graham, K Benjamin, R Hoda, M Krishna, M Romano, M Wallace, E Garrett-Mayer and M Mitas

    beta2microglobulin mRNA expression levels are prognostic for lymph node metastasis in colorectal cancer patients

    advance online publication, 2008-05-27 00:00:00.000;

    doi:10.1038/sj.bjc.6604399

  • Garrigue, J S

    S A Veltkamp, B Thijssen, J S Garrigue, G Lambert, F Lallemand, F Binlich, A D R Huitema, B Nuijen, A Nol, J H Beijnen and J H M Schellens

    A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancer

    advance online publication, 2006-08-22 00:00:00.000;

    doi:10.1038/sj.bjc.6603312

  • Garrison, L P

    J Cassidy, J-Y Douillard, C Twelves, J J McKendrick, W Scheithauer, I Bustová, P G Johnston, K Lesniewski-Kmak, S Jelic, G Fountzilas, F Coxon, E Díaz-Rubio, T S Maughan, A Malzyner, O Bertetto, A Beham, A Figer, P Dufour, K K Patel, W Cowell and L P Garrison

    Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial

    doi:10.1038/sj.bjc.6603059

  • Garrote, L Fernandez

    L Fernandez Garrote, R Herrero, R M Ortiz Reyes, S Vaccarella, J Lence Anta, L Ferbeye, N Muñoz and S Franceschi

    Risk factors for cancer of the oral cavity and oro-pharynx in Cuba

    doi:10.1054/bjoc.2000.1825

  • Garsd, A

    R Trauger, E Corey, D Bell, S White, A Garsd, D Stickney, C Reading and J Frincke

    Inhibition of androstenediol-dependent LNCaP tumour growth by 17alpha-ethynyl-5alpha-androstane-3alpha, 17beta-diol (HE3235)

    doi:10.1038/sj.bjc.6604987

  • Garssen, J

    J Faber, P Vos, D Kegler, K van Norren, J M Argilés, A Laviano, J Garssen and A van Helvoort

    Beneficial immune modulatory effects of a specific nutritional combination in a murine model for cancer cachexia

    advance online publication, 2008-11-18 00:00:00.000;

    doi:10.1038/sj.bjc.6604785

  • Garte, S

    V Paracchini, A Nanni Costa, S Garte and E Taioli

    Role of simian virus 40 in cancer incidence in solid organ transplant patients

    advance online publication, 2006-04-18 00:00:00.000;

    doi:10.1038/sj.bjc.6603107